Bismuth dipropylacetate

On 1 register2 medicines2 companies

Classification

Each register with its number of medicines and a few of them.

Every register, a page at a time. Strengths and packs are on each medicine’s page.

2 results

Medicine	Register	Strength	Form	Status	Holder
Neo-Laryngobis	Canada	135 MG	Suppository	Marketed	Teva Canada Limited
Neo Laryngobis Enf	Canada	67.5 MG	Suppository	Cancelled	Lab Bio Chimique INC.,Division of Technilab Pharma INC.

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.